Microalbuminuria, Impaired Glucose Tolerance, and Their Prognostic Implications in Patients With Chronic Heart Failure: Insights From the SUPPlemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using OlmesaRTan (SUPPORT) Trial

被引：0
|
作者：
Nochioka, Kotaro
Sakata, Yasuhiko
Oikawa, Takuya
Abe, Ruri
Kasahara, Shintaro
Sato, Masayuki
Aoyanagi, Hajime
Shiroto, Takashi
Takahashi, Jun
Miyata, Satoshi
Shimokawa, Hiroaki
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Heart failure; Insulin resistance; Diabetes Mellitus; Kidney;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14748
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of Additive Use of Olmesartan in Patients With Chronic Heart Failure: The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan (SUPPORT) Trial
    Sakata, Yasuhiko
    Shiba, Nobuyuki
    Takahashi, Jun
    Miyata, Satoshi
    Nochioka, Kotaro
    Miura, Masanobu
    Takada, Tsuyoshi
    Shimokawa, Hiroaki
    CIRCULATION, 2014, 130 (23) : 2116 - 2116
  • [2] Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
    Sakata, Yasuhiko
    Shiba, Nobuyuki
    Takahashi, Jun
    Miyata, Satoshi
    Nochioka, Kotaro
    Miura, Masanobu
    Takada, Tsuyoshi
    Saga, Chiharu
    Shinozaki, Tsuyoshi
    Sugi, Masafumi
    Nakagawa, Makoto
    Sekiguchi, Nobuyo
    Komaru, Tatsuya
    Kato, Atsushi
    Fukuchi, Mitsumasa
    Nozaki, Eiji
    Hiramoto, Tetsuya
    Inoue, Kanichi
    Goto, Toshikazu
    Ohe, Masatoshi
    Tamaki, Kenji
    Ibayashi, Setsuro
    Ishide, Nobumasa
    Maruyama, Yukio
    Tsuji, Ichiro
    Shimokawa, Hiroaki
    EUROPEAN HEART JOURNAL, 2015, 36 (15) : 915 - 923A
  • [3] Supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial-Rationale and design
    Sakata, Yasuhiko
    Nochioka, Kotaro
    Miura, Masanobu
    Takada, Tsuyoshi
    Tadaki, Soichiro
    Miyata, Satoshi
    Shiba, Nobuyuki
    Shimokawa, Hiroaki
    JOURNAL OF CARDIOLOGY, 2013, 62 (1-2) : 31 - 36
  • [4] Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial
    Nochioka, Kotaro
    Sakata, Yasuhiko
    Miura, Masanobu
    Shiroto, Takashi
    Takahashi, Jun
    Saga, Chie
    Ikeno, Yasuko
    Shiba, Nobuyuki
    Shinozaki, Tsuyoshi
    Sugi, Masafumi
    Nakagawa, Makoto
    Komaru, Tatsuya
    Kato, Atsushi
    Nozaki, Eiji
    Iwabuchi, Kaoru
    Hiramoto, Tetsuya
    Inoue, Kanichi
    Ohe, Masatoshi
    Tamaki, Kenji
    Tsuji, Ichiro
    Shimokawa, Hiroaki
    ESC HEART FAILURE, 2019, 6 (06): : 1252 - 1261
  • [5] Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure - Results from the Valsartan Heart Failure Trial
    Cohn, JN
    Anand, IS
    Latini, R
    Masson, S
    Chiang, YT
    Glazer, R
    CIRCULATION, 2003, 108 (11) : 1306 - 1309
  • [6] Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial
    Wamil, Malgorzata
    McMurray, John J. V.
    Scott, Charles A. B.
    Coleman, Ruth L.
    Sun, Yihong
    Standl, Eberhard
    Ryden, Lars
    Holman, Rury R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [7] Impaired glucose tolerance worsens exercise capacity and ventilatory response to exercise in patients with chronic heart failure
    Straburzynska-Migaj, Ewa
    Ochotny, Romuald
    Cieslinski, Andrzej
    KARDIOLOGIA POLSKA, 2007, 65 (04) : 354 - 362
  • [8] Prevalence and Prognostic Value of Elevated Urinary Albumin Excretion in Patients With Chronic Heart Failure Data From the GISSI-Heart Failure Trial
    Masson, Serge
    Latini, Roberto
    Milani, Valentina
    Moretti, Luciano
    Rossi, Maria Grazia
    Carbonieri, Emanuele
    Frisinghelli, Anna
    Minneci, Calogero
    Valisi, Massimiliano
    Maggioni, Aldo P.
    Marchioli, Roberto
    Tognoni, Gianni
    Tavazzi, Luigi
    CIRCULATION-HEART FAILURE, 2010, 3 (01) : 65 - 72
  • [9] Effects of a changeover from other angiotensin II receptor blockers to olmesartan on left ventricular hypertrophy in heart failure patients
    Hiroyuki Shimoura
    Hidekazu Tanaka
    Kensuke Matsumoto
    Yasuhide Mochizuki
    Yutaka Hatani
    Keiko Hatazawa
    Hiroki Matsuzoe
    Junichi Ooka
    Hiroyuki Sano
    Takuma Sawa
    Yoshiki Motoji
    Keiko Ryo-Koriyama
    Ken-ichi Hirata
    Heart and Vessels, 2017, 32 : 584 - 590
  • [10] Effects of a changeover from other angiotensin II receptor blockers to olmesartan on left ventricular hypertrophy in heart failure patients
    Shimoura, Hiroyuki
    Tanaka, Hidekazu
    Matsumoto, Kensuke
    Mochizuki, Yasuhide
    Hatani, Yutaka
    Hatazawa, Keiko
    Matsuzoe, Hiroki
    Ooka, Junichi
    Sano, Hiroyuki
    Sawa, Takuma
    Motoji, Yoshiki
    Ryo-Koriyama, Keiko
    Hirata, Ken-ichi
    HEART AND VESSELS, 2017, 32 (05) : 584 - 590
12345